Top Markets
Coin of the day
Golden Biotechnology Corporation Golden Biotechnology Corporation

Golden Biotechnology Corporation

4132
Rang in Aktien #29678
Golden Biotechnology Corporation, founded in 2002 and based in New Taipei City,... Golden Biotechnology Corporation, founded in 2002 and based in New Taipei City, Taiwan, is engaged in both pharmaceutical drug discovery and the production of health-enhancing dietary supplements. The company operates internationally, serving markets in Taiwan, the United States, Japan, China, Korea, and Singapore. Its varied product line includes several health supplements: Liverty, formulated to support liver function and help alleviate fatigue. Rasle, which serves as an adjunctive therapy for autoimmune conditions. ZSAINO, a nutritional product designed to aid recovery from illness and boost general well-being. UMOOZE, a specialized herbal blend targeting optimal health for men. Furthermore, Golden Biotechnology is developing Antroquinonol, an anticancer molecule. This compound is currently utilized in the treatment of severe conditions such as pancreatic cancer, acute myeloid leukemia, and hepatocellular carcinoma, in addition to addressing hypercholesterolemia and hyperlipidemia.
Aktienkurs
$0.11034263
Zuletzt synchronisiert: 2026-04-09
Marktkapitalisierung
$20.11M
Veränderung (1 Tag)
-31.83%
Veränderung (1 Jahr)
-73.09%
Land
TW
Handel Golden Biotechnology Corporation (4132)

Kategorie

Kursverlauf für Golden Biotechnology Corporation (4132)
Höchster Schlusskurs: $0.13 am 2026-04-01

Niedrigster Schlusskurs: $0.82 am 2012-06-01
Kursverlauf der Aktie von Golden Biotechnology Corporation von 2012 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -34.43%
2025 52.97%
2024 -61.33%
2023 -40.03%
2022 -43.02%
2021 127.12%
2020 48.00%
2019 20.35%
2018 -31.64%
2017 -10.81%
2016 -8.54%
2015 52.98%
2014 0.33%
2013 24.21%
2012 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$171.67 -
DE
$163.45 26.45%
DE
$37.64 23.14%
JP
$224.22 33.92%
CH
$20.96 12.20%
IN